Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow Reinvestment Rate
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥25.80 Million (capex CN¥25.80 Million ) from operating cash flow of CN¥112.12 Million. Check 000623 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. Explore how much of Jilin Aodong Pharmaceutical Group Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.17x | CN¥862.15 Million | CN¥272.26 Million | CN¥128.45 Million | ▼ -80.8% |
| 2024 | 16.48x | CN¥980.49 Million | CN¥59.48 Million | CN¥273.98 Million | ▼ -5.2% |
| 2023 | 17.38x | CN¥1.18 Billion | CN¥68.06 Million | CN¥419.52 Million | ▲ +432.8% |
| 2022 | 3.26x | CN¥1.38 Billion | CN¥423.86 Million | CN¥270.97 Million | ▼ -24.0% |
| 2021 | 4.29x | CN¥1.39 Billion | CN¥324.85 Million | CN¥313.30 Million | ▲ +417.1% |
| 2020 | 0.83x | CN¥323.95 Million | CN¥390.41 Million | CN¥227.38 Million | ▼ -4.3% |
| 2019 | 0.87x | CN¥328.96 Million | CN¥379.46 Million | CN¥222.40 Million | ▼ -87.2% |
| 2018 | 6.76x | CN¥2.35 Billion | CN¥347.64 Million | CN¥245.30 Million | ▲ +217.9% |
| 2017 | 2.13x | CN¥545.48 Million | CN¥256.49 Million | CN¥83.93 Million | ▼ -3.8% |
| 2016 | 2.21x | CN¥738.12 Million | CN¥333.81 Million | CN¥158.03 Million | ▼ -40.3% |
| 2015 | 3.70x | CN¥1.44 Billion | CN¥388.03 Million | CN¥334.11 Million | ▲ +166.0% |
| 2014 | 1.39x | CN¥402.01 Million | CN¥288.83 Million | CN¥402.01 Million | ▼ -9.4% |
| 2013 | 1.54x | CN¥309.01 Million | CN¥201.22 Million | CN¥309.01 Million | ▲ +28.0% |
| 2012 | 1.20x | CN¥326.80 Million | CN¥272.40 Million | CN¥326.80 Million | ▼ -71.6% |
| 2011 | 4.23x | CN¥457.72 Million | CN¥108.30 Million | CN¥457.72 Million | ▲ +384.4% |
| 2010 | 0.87x | CN¥152.00 Million | CN¥174.22 Million | CN¥152.00 Million | ▲ +409.0% |
| 2009 | 0.17x | CN¥36.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▲ +27.8% |
| 2008 | 0.13x | CN¥31.52 Million | CN¥235.03 Million | CN¥31.52 Million | ▲ +31.5% |
| 2007 | 0.10x | CN¥39.24 Million | CN¥384.69 Million | CN¥39.24 Million | ▼ -66.3% |
| 2006 | 0.30x | CN¥56.87 Million | CN¥187.99 Million | CN¥56.87 Million | ▼ -26.0% |
| 2005 | 0.41x | CN¥55.68 Million | CN¥136.26 Million | CN¥55.68 Million | ▲ +93.4% |
| 2004 | 0.21x | CN¥46.19 Million | CN¥218.53 Million | CN¥46.19 Million | ▼ -66.0% |
| 2003 | 0.62x | CN¥91.89 Million | CN¥147.65 Million | CN¥91.89 Million | ▼ -58.4% |
| 2001 | 1.49x | CN¥207.37 Million | CN¥138.76 Million | CN¥207.37 Million | ▼ -29.8% |
| 2000 | 2.13x | CN¥163.90 Million | CN¥77.04 Million | CN¥163.90 Million | ▲ +232.4% |
| 1999 | 0.64x | CN¥70.52 Million | CN¥110.18 Million | CN¥70.52 Million | — |